Talk:PR-000608

	This article was reviewed by member(s) of WikiProject Articles for creation. The project works to allow users to contribute quality articles and media files to the encyclopedia and track their progress as they are developed. To participate, please visit the project page for more information.Articles for creationWikipedia:WikiProject Articles for creationTemplate:WikiProject Articles for creationAfC
	This article was accepted from this draft on 28 April 2025 by reviewer Fancy Refrigerator (talk · contribs).

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Low	This article has been rated as Low-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals
Low	This article has been rated as Low-importance on the project's importance scale.

Somewhat vaguely related calcium antagonist cardioprotectors are called draflazine & mioflazine & soluflazine. These are of structural significance since they are also representative of a class of compounds that are all 4,4-diphenylbutylpiperazine containing agents. — Preceding unsigned comment added by 92.31.192.97 (talk) 16:08, 22 May 2025 (UTC)Reply